WALKME LTD (WKME)

IL0011765851 - Common Stock

13.84  -0.03 (-0.22%)

Fundamental Rating

4

Taking everything into account, WKME scores 4 out of 10 in our fundamental rating. WKME was compared to 277 industry peers in the Software industry. While WKME has a great health rating, there are worries on its profitability. WKME has a decent growth rate and is not valued too expensively.



2

1. Profitability

1.1 Basic Checks

WKME had positive earnings in the past year.
In the past year WKME had a positive cash flow from operations.
In the past 5 years WKME always reported negative net income.
WKME had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

WKME's Return On Assets of -8.34% is in line compared to the rest of the industry. WKME outperforms 45.65% of its industry peers.
WKME has a Return On Equity (-14.61%) which is in line with its industry peers.
Industry RankSector Rank
ROA -8.34%
ROE -14.61%
ROIC N/A
ROA(3y)-18.22%
ROA(5y)-23.44%
ROE(3y)-30.9%
ROE(5y)-46.52%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

WKME has a better Gross Margin (84.40%) than 92.03% of its industry peers.
In the last couple of years the Gross Margin of WKME has grown nicely.
WKME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

WKME does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WKME has more shares outstanding
WKME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 3.11 indicates that WKME is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.11, WKME perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
There is no outstanding debt for WKME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.11
ROIC/WACCN/A
WACC9.43%

2.3 Liquidity

A Current Ratio of 2.11 indicates that WKME has no problem at all paying its short term obligations.
WKME has a better Current ratio (2.11) than 63.41% of its industry peers.
WKME has a Quick Ratio of 2.11. This indicates that WKME is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.11, WKME is doing good in the industry, outperforming 64.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 135.29% over the past year.
The Revenue has been growing slightly by 6.14% in the past year.
WKME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.65% yearly.
EPS 1Y (TTM)135.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%187.5%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y21.65%
Revenue growth 5YN/A
Sales Q2Q%4.07%

3.2 Future

Based on estimates for the next years, WKME will show a very strong growth in Earnings Per Share. The EPS will grow by 71.00% on average per year.
The Revenue is expected to grow by 8.86% on average over the next years. This is quite good.
EPS Next Y593.97%
EPS Next 2Y205.59%
EPS Next 3Y139.86%
EPS Next 5Y71%
Revenue Next Year5.78%
Revenue Next 2Y7.65%
Revenue Next 3Y9.34%
Revenue Next 5Y8.86%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 76.89, which means the current valuation is very expensive for WKME.
Compared to the rest of the industry, the Price/Earnings ratio of WKME is on the same level as its industry peers.
When comparing the Price/Earnings ratio of WKME to the average of the S&P500 Index (28.16), we can say WKME is valued expensively.
Based on the Price/Forward Earnings ratio of 49.40, the valuation of WKME can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WKME is on the same level as its industry peers.
WKME's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.02.
Industry RankSector Rank
PE 76.89
Fwd PE 49.4

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, WKME is valued a bit cheaper than the industry average as 72.46% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 32.13
EV/EBITDA N/A

4.3 Compensation for Growth

WKME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WKME's earnings are expected to grow with 139.86% in the coming years.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y205.59%
EPS Next 3Y139.86%

0

5. Dividend

5.1 Amount

No dividends for WKME!.
Industry RankSector Rank
Dividend Yield N/A

WALKME LTD

NASDAQ:WKME (7/2/2024, 10:47:19 AM)

13.84

-0.03 (-0.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.29B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 76.89
Fwd PE 49.4
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.34%
ROE -14.61%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 84.4%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)135.29%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y593.97%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.14%
Revenue growth 3Y21.65%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y